YMAB

Y mAbs Therapeutics Stock Price

42.21
0.13 (0.31%)
Upgrade to Real-Time
Regular Market
42.21
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.13 0.31% 42.21 41.01 43.615 42.72 42.08 12:21:44
Bid Price Ask Price Spread Spread % News
42.10 42.43 0.33 0.78% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,749 78,717 $ 41.85 $ 3,294,608 295,629 14.16 - 50.49
Last Trade Time Type Quantity Stock Price Currency
12:21:44 5 $ 42.40 USD

Y mAbs Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.68B 39.76M 29.66M $ - $ - -2.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -15.00 1.10%

more financials information »

Y mAbs Therapeutics News

Date Time Source News Article
6/30/202016:27Edgar (US Regulatory)Current Report Filing (8-k)
6/30/202016:01GlobeNewswire Inc.Y-mAbs Announces Initiation of Submission of Omburtamab..
6/24/202016:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/24/202016:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/24/202016:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/24/202016:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
6/24/202016:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical YMAB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week48.4650.4941.0145.23463,935-6.25-12.9%
1 Month42.0450.4940.0945.29294,9510.170.4%
3 Months28.3050.4928.0040.02255,97813.9149.15%
6 Months31.6950.4914.1633.39234,63610.5233.2%
1 Year23.0750.4914.1631.28216,30519.1482.96%
3 Years26.5050.4914.1628.76176,44315.7159.28%
5 Years26.5050.4914.1628.76176,44315.7159.28%

Y mAbs Therapeutics Description

Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.
Your Recent History
NASDAQ
YMAB
Y mAbs The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200702 16:36:47